DIVISLAB's weekly return of 1.7% was modest, but its volatility of 14.27% suggests a relatively stable performance. Compared to its peers, DIVISLAB underperformed DRREDDY but outperformed CIPLA, and was on par with SUNPHARMA. The stock's Sharpe Ratio of 0.47 indicates a relatively low risk-adjusted return, while its Max Drawdown of -0.51% suggests a moderate level of risk.

[Volatility: 14.27%]